Join us during SOT Annual Meeting in Baltimore MD, USA for our exhibitor hosted session with Citoxlab.
Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Lines.
In the last 5 years, FDA has actively characterized innovative ECG analysis methods for proarrhythmia assessments in clinical trials. ECG is a cornerstone of cardiac safety monitoring in toxicology and safety pharmacology with similarities between clinical and non-clinical evaluations.
The session will compare well established ECG analysis methods used in toxicology with novel strategies that may offer lower false positive rates. Critical success factors in the analysis of pre-clinical ECGs will also be discussed.
The ECG’s acquired during this study were collected by easyTEL+ L EEEETA implanted telemetry.
WHEN: March 12, 2018 / 12:00 – 13:00
WHERE: SOT & ToxExpo 2019, Baltimore Convention Center / Meeting Room 337
SPEAKER: Dr. Simon Authier – Deputy Chief Scientific Officer, Citoxlab North America
How to find us?